APO Research

APO RESEARCH · REPORT

Biomedical Cold Chain Services

Selected research

Market Analysis & Forecast

Global Biomedical Cold Chain Services Market Analysis and Forecast 2026-2032

Market perspective

The global Biomedical Cold Chain Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biomedical Cold Chain Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biomedical Cold Chain Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biomedical Cold Chain Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biomedical Cold Chain Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biomedical Cold Chain Services include Csafe, DS Smith, Skycell, Sofrigam, Cold Chain Technologies, Nichirei Logistics Group, Sonoco, Alloga and Hemisphere Freight Services, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biomedical Cold Chain Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biomedical Cold Chain Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Biomedical Cold Chain Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biomedical Cold Chain Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biomedical Cold Chain Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biomedical Cold Chain Services revenue, projected growth trends, production technology, application and end-user industry.

Biomedical Cold Chain Services Segment by Company

Csafe

DS Smith

Skycell

Sofrigam

Cold Chain Technologies

Nichirei Logistics Group

Sonoco

Alloga

Hemisphere Freight Services

TEK Freight

Jump Up Logistics

Courier Express

Biocair

Tower Cold Chain

Patheon

Movianto

Pharmaceutical Technology

Biomedical Cold Chain Services Segment by Type

Shipping

Air Transport

Land Transportation

Others

Biomedical Cold Chain Services Segment by Application

Pharmaceuticals

Blood Supplies

Others

Biomedical Cold Chain Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical Cold Chain Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomedical Cold Chain Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical Cold Chain Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biomedical Cold Chain Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biomedical Cold Chain Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomedical Cold Chain Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biomedical Cold Chain Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Shipping Major Player Table 3. Air Transport Major Player Table 4. Land Transportation Major Player Table 5. Others Major Player Table 6. Global Biomedical Cold Chain Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceuticals Major Player Table 8. Blood Supplies Major Player Table 9. Others Major Player Table 10. Biomedical Cold Chain Services Industry Trends Table 11. Biomedical Cold Chain Services Industry Drivers Table 12. Biomedical Cold Chain Services Industry Opportunities and Challenges Table 13. Biomedical Cold Chain Services Industry Restraints Table 14. Global Biomedical Cold Chain Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Biomedical Cold Chain Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Biomedical Cold Chain Services Market Share by Region (2021-2026) Table 17. Global Biomedical Cold Chain Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Biomedical Cold Chain Services Market Share by Region (2027-2032) Table 19. Global Biomedical Cold Chain Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Biomedical Cold Chain Services Revenue Market Share by Players (2021-2026) Table 21. Global Biomedical Cold Chain Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Biomedical Cold Chain Services Key Players Headquarters & Area Served Table 23. Global Biomedical Cold Chain Services Players, Product Type & Application Table 24. Global Biomedical Cold Chain Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Biomedical Cold Chain Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Biomedical Cold Chain Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Biomedical Cold Chain Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Biomedical Cold Chain Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Biomedical Cold Chain Services Revenue Market Share by Type (2021-2026) Table 31. Global Biomedical Cold Chain Services Revenue Market Share by Type (2027-2032) Table 32. Global Biomedical Cold Chain Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Biomedical Cold Chain Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Biomedical Cold Chain Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Biomedical Cold Chain Services Revenue Market Share by Application (2021-2026) Table 36. Global Biomedical Cold Chain Services Revenue Market Share by Application (2027-2032) Table 37. Csafe Company Information Table 38. Csafe Business Overview Table 39. Csafe Biomedical Cold Chain Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Csafe Biomedical Cold Chain Services Product Portfolio Table 41. Csafe Recent Development Table 42. DS Smith Company Information Table 43. DS Smith Business Overview Table 44. DS Smith Biomedical Cold Chain Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. DS Smith Biomedical Cold Chain Services Product Portfolio Table 46. DS Smith Recent Development Table 47. Skycell Company Information Table 48. Skycell Business Overview Table 49. Skycell Biomedical Cold Chain Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Skycell Biomedical Cold Chain Services Product Portfolio Table 51. Skycell Recent Development Table 52. Sofrigam Company Information Table 53. Sofrigam Business Overview Table 54. Sofrigam Biomedical Cold Chain Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Sofrigam Biomedical Cold Chain Services Product Portfolio Table 56. Sofrigam Recent Development Table 57. Cold Chain Technologies Company Information Table 58. Cold Chain Technologies Business Overview Table 59. Cold Chain Technologies Biomedical Cold Chain Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Cold Chain Technologies Biomedical Cold Chain Services Product Portfolio Table 61. Cold Chain Technologies Recent Development Table 62. Nichirei Logistics Group Company Information Table 63. Nichirei Logistics Group Business Overview Table 64. Nichirei Logistics Group Biomedical Cold Chain Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Nichirei Logistics Group Biomedical Cold Chain Services Product Portfolio Table 66. Nichirei Logistics Group Recent Development Table 67. Sonoco Company Information Table 68. Sonoco Business Overview Table 69. Sonoco Biomedical Cold Chain Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Sonoco Biomedical Cold Chain Services Product Portfolio Table 71. Sonoco Recent Development Table 72. Alloga Company Information Table 73. Alloga Business Overview Table 74. Alloga Biomedical Cold Chain Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Alloga Biomedical Cold Chain Services Product Portfolio Table 76. Alloga Recent Development Table 77. Hemisphere Freight Services Company Information Table 78. Hemisphere Freight Services Business Overview Table 79. Hemisphere Freight Services Biomedical Cold Chain Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Hemisphere Freight Services Biomedical Cold Chain Services Product Portfolio Table 81. Hemisphere Freight Services Recent Development Table 82. TEK Freight Company Information Table 83. TEK Freight Business Overview Table 84. TEK Freight Biomedical Cold Chain Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. TEK Freight Biomedical Cold Chain Services Product Portfolio Table 86. TEK Freight Recent Development Table 87. Jump Up Logistics Company Information Table 88. Jump Up Logistics Business Overview Table 89. Jump Up Logistics Biomedical Cold Chain Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Jump Up Logistics Biomedical Cold Chain Services Product Portfolio Table 91. Jump Up Logistics Recent Development Table 92. Courier Express Company Information Table 93. Courier Express Business Overview Table 94. Courier Express Biomedical Cold Chain Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Courier Express Biomedical Cold Chain Services Product Portfolio Table 96. Courier Express Recent Development Table 97. Biocair Company Information Table 98. Biocair Business Overview Table 99. Biocair Biomedical Cold Chain Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Biocair Biomedical Cold Chain Services Product Portfolio Table 101. Biocair Recent Development Table 102. Tower Cold Chain Company Information Table 103. Tower Cold Chain Business Overview Table 104. Tower Cold Chain Biomedical Cold Chain Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Tower Cold Chain Biomedical Cold Chain Services Product Portfolio Table 106. Tower Cold Chain Recent Development Table 107. Patheon Company Information Table 108. Patheon Business Overview Table 109. Patheon Biomedical Cold Chain Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Patheon Biomedical Cold Chain Services Product Portfolio Table 111. Patheon Recent Development Table 112. Movianto Company Information Table 113. Movianto Business Overview Table 114. Movianto Biomedical Cold Chain Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Movianto Biomedical Cold Chain Services Product Portfolio Table 116. Movianto Recent Development Table 117. Pharmaceutical Technology Company Information Table 118. Pharmaceutical Technology Business Overview Table 119. Pharmaceutical Technology Biomedical Cold Chain Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Pharmaceutical Technology Biomedical Cold Chain Services Product Portfolio Table 121. Pharmaceutical Technology Recent Development Table 122. North America Biomedical Cold Chain Services Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Biomedical Cold Chain Services Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Biomedical Cold Chain Services Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Biomedical Cold Chain Services Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Biomedical Cold Chain Services Revenue by Country (2021-2026) & (US$ Million) Table 128. North America Biomedical Cold Chain Services Revenue by Country (US$ Million) & (2027-2032) Table 129. Europe Biomedical Cold Chain Services Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Biomedical Cold Chain Services Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Biomedical Cold Chain Services Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Biomedical Cold Chain Services Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Biomedical Cold Chain Services Revenue by Country (2021-2026) & (US$ Million) Table 135. Europe Biomedical Cold Chain Services Revenue by Country (US$ Million) & (2027-2032) Table 136. China Biomedical Cold Chain Services Revenue by Type (2021-2026) & (US$ Million) Table 137. China Biomedical Cold Chain Services Revenue by Type (2027-2032) & (US$ Million) Table 138. China Biomedical Cold Chain Services Revenue by Application (2021-2026) & (US$ Million) Table 139. China Biomedical Cold Chain Services Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Biomedical Cold Chain Services Revenue by Type (2021-2026) & (US$ Million) Table 141. Asia Biomedical Cold Chain Services Revenue by Type (2027-2032) & (US$ Million) Table 142. Asia Biomedical Cold Chain Services Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Biomedical Cold Chain Services Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Biomedical Cold Chain Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Biomedical Cold Chain Services Revenue by Region (US$ Million) & (2021-2026) Table 146. Asia Biomedical Cold Chain Services Revenue by Region (US$ Million) & (2027-2032) Table 147. SAMEA Biomedical Cold Chain Services Revenue by Type (2021-2026) & (US$ Million) Table 148. SAMEA Biomedical Cold Chain Services Revenue by Type (2027-2032) & (US$ Million) Table 149. SAMEA Biomedical Cold Chain Services Revenue by Application (2021-2026) & (US$ Million) Table 150. SAMEA Biomedical Cold Chain Services Revenue by Application (2027-2032) & (US$ Million) Table 151. SAMEA Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. SAMEA Biomedical Cold Chain Services Revenue by Country (2021-2026) & (US$ Million) Table 153. SAMEA Biomedical Cold Chain Services Revenue by Country (US$ Million) & (2027-2032) Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Biomedical Cold Chain Services Image Figure 2. Global Biomedical Cold Chain Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomedical Cold Chain Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Shipping Image Figure 5. Air Transport Image Figure 6. Land Transportation Image Figure 7. Others Image Figure 8. Global Biomedical Cold Chain Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Biomedical Cold Chain Services Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceuticals Image Figure 11. Blood Supplies Image Figure 12. Others Image Figure 13. Global Biomedical Cold Chain Services Market Size (US$ Million) & (2021-2032) Figure 14. Global Biomedical Cold Chain Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Biomedical Cold Chain Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Biomedical Cold Chain Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Biomedical Cold Chain Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biomedical Cold Chain Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Biomedical Cold Chain Services Revenue Market Share by Type (2021-2032) Figure 21. Global Biomedical Cold Chain Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biomedical Cold Chain Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Biomedical Cold Chain Services Revenue Market Share by Application (2021-2032) Figure 24. North America Biomedical Cold Chain Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Biomedical Cold Chain Services Revenue Share by Type (2021-2032) Figure 26. North America Biomedical Cold Chain Services Revenue Share by Application (2021-2032) Figure 27. North America Biomedical Cold Chain Services Revenue Share by Country (2021-2032) Figure 28. United States Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Biomedical Cold Chain Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Biomedical Cold Chain Services Revenue Share by Type (2021-2032) Figure 33. Europe Biomedical Cold Chain Services Revenue Share by Application (2021-2032) Figure 34. Europe Biomedical Cold Chain Services Revenue Share by Country (2021-2032) Figure 35. Germany Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Biomedical Cold Chain Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Biomedical Cold Chain Services Revenue Share by Type (2021-2032) Figure 45. China Biomedical Cold Chain Services Revenue Share by Application (2021-2032) Figure 46. Asia Biomedical Cold Chain Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Biomedical Cold Chain Services Revenue Share by Type (2021-2032) Figure 48. Asia Biomedical Cold Chain Services Revenue Share by Application (2021-2032) Figure 49. Asia Biomedical Cold Chain Services Revenue Share by Region (2021-2032) Figure 50. Japan Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Biomedical Cold Chain Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Biomedical Cold Chain Services Revenue Share by Type (2021-2032) Figure 58. SAMEA Biomedical Cold Chain Services Revenue Share by Application (2021-2032) Figure 59. SAMEA Biomedical Cold Chain Services Revenue Share by Country (2021-2032) Figure 60. Brazil Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Biomedical Cold Chain Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Shipping
  • Air Transport
  • Land Transportation
  • Others
Applications
  • Pharmaceuticals
  • Blood Supplies
  • Others
Companies covered
  • Csafe
  • DS Smith
  • Skycell
  • Sofrigam
  • Cold Chain Technologies
  • Nichirei Logistics Group
  • Sonoco
  • Alloga
  • Hemisphere Freight Services
  • TEK Freight
  • Jump Up Logistics
  • Courier Express
  • Biocair
  • Tower Cold Chain
  • Patheon
  • Movianto
  • Pharmaceutical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biomedical Cold Chain Services Market by Type
  3. 1.2.1 Global Biomedical Cold Chain Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Shipping
  5. 1.2.3 Air Transport
  6. 1.2.4 Land Transportation
  7. 1.2.5 Others
  8. 1.3 Biomedical Cold Chain Services Market by Application
  9. 1.3.1 Global Biomedical Cold Chain Services Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceuticals
  11. 1.3.3 Blood Supplies
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Biomedical Cold Chain Services Market Dynamics
  1. 2.1 Biomedical Cold Chain Services Industry Trends
  2. 2.2 Biomedical Cold Chain Services Industry Drivers
  3. 2.3 Biomedical Cold Chain Services Industry Opportunities and Challenges
  4. 2.4 Biomedical Cold Chain Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biomedical Cold Chain Services Market Perspective (2021-2032)
  2. 3.2 Global Biomedical Cold Chain Services Growth Trends by Region
  3. 3.2.1 Global Biomedical Cold Chain Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biomedical Cold Chain Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Biomedical Cold Chain Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biomedical Cold Chain Services Revenue by Players
  2. 4.1.1 Global Biomedical Cold Chain Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Biomedical Cold Chain Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biomedical Cold Chain Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biomedical Cold Chain Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biomedical Cold Chain Services Key Players Headquarters & Area Served
  7. 4.4 Global Biomedical Cold Chain Services Players, Product Type & Application
  8. 4.5 Global Biomedical Cold Chain Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biomedical Cold Chain Services Market CR5 and HHI
  11. 4.6.3 2025 Biomedical Cold Chain Services Tier 1, Tier 2, and Tier 3
5 Biomedical Cold Chain Services Market Size by Type
  1. 5.1 Global Biomedical Cold Chain Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biomedical Cold Chain Services Revenue by Type (2021-2032)
  3. 5.3 Global Biomedical Cold Chain Services Revenue Market Share by Type (2021-2032)
6 Biomedical Cold Chain Services Market Size by Application
  1. 6.1 Global Biomedical Cold Chain Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biomedical Cold Chain Services Revenue by Application (2021-2032)
  3. 6.3 Global Biomedical Cold Chain Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Csafe
  2. 7.1.1 Csafe Company Information
  3. 7.1.2 Csafe Business Overview
  4. 7.1.3 Csafe Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Csafe Biomedical Cold Chain Services Product Portfolio
  6. 7.1.5 Csafe Recent Developments
  7. 7.2 DS Smith
  8. 7.2.1 DS Smith Company Information
  9. 7.2.2 DS Smith Business Overview
  10. 7.2.3 DS Smith Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 DS Smith Biomedical Cold Chain Services Product Portfolio
  12. 7.2.5 DS Smith Recent Developments
  13. 7.3 Skycell
  14. 7.3.1 Skycell Company Information
  15. 7.3.2 Skycell Business Overview
  16. 7.3.3 Skycell Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Skycell Biomedical Cold Chain Services Product Portfolio
  18. 7.3.5 Skycell Recent Developments
  19. 7.4 Sofrigam
  20. 7.4.1 Sofrigam Company Information
  21. 7.4.2 Sofrigam Business Overview
  22. 7.4.3 Sofrigam Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sofrigam Biomedical Cold Chain Services Product Portfolio
  24. 7.4.5 Sofrigam Recent Developments
  25. 7.5 Cold Chain Technologies
  26. 7.5.1 Cold Chain Technologies Company Information
  27. 7.5.2 Cold Chain Technologies Business Overview
  28. 7.5.3 Cold Chain Technologies Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Cold Chain Technologies Biomedical Cold Chain Services Product Portfolio
  30. 7.5.5 Cold Chain Technologies Recent Developments
  31. 7.6 Nichirei Logistics Group
  32. 7.6.1 Nichirei Logistics Group Company Information
  33. 7.6.2 Nichirei Logistics Group Business Overview
  34. 7.6.3 Nichirei Logistics Group Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Nichirei Logistics Group Biomedical Cold Chain Services Product Portfolio
  36. 7.6.5 Nichirei Logistics Group Recent Developments
  37. 7.7 Sonoco
  38. 7.7.1 Sonoco Company Information
  39. 7.7.2 Sonoco Business Overview
  40. 7.7.3 Sonoco Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sonoco Biomedical Cold Chain Services Product Portfolio
  42. 7.7.5 Sonoco Recent Developments
  43. 7.8 Alloga
  44. 7.8.1 Alloga Company Information
  45. 7.8.2 Alloga Business Overview
  46. 7.8.3 Alloga Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Alloga Biomedical Cold Chain Services Product Portfolio
  48. 7.8.5 Alloga Recent Developments
  49. 7.9 Hemisphere Freight Services
  50. 7.9.1 Hemisphere Freight Services Company Information
  51. 7.9.2 Hemisphere Freight Services Business Overview
  52. 7.9.3 Hemisphere Freight Services Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Hemisphere Freight Services Biomedical Cold Chain Services Product Portfolio
  54. 7.9.5 Hemisphere Freight Services Recent Developments
  55. 7.10 TEK Freight
  56. 7.10.1 TEK Freight Company Information
  57. 7.10.2 TEK Freight Business Overview
  58. 7.10.3 TEK Freight Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 TEK Freight Biomedical Cold Chain Services Product Portfolio
  60. 7.10.5 TEK Freight Recent Developments
  61. 7.11 Jump Up Logistics
  62. 7.11.1 Jump Up Logistics Company Information
  63. 7.11.2 Jump Up Logistics Business Overview
  64. 7.11.3 Jump Up Logistics Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Jump Up Logistics Biomedical Cold Chain Services Product Portfolio
  66. 7.11.5 Jump Up Logistics Recent Developments
  67. 7.12 Courier Express
  68. 7.12.1 Courier Express Company Information
  69. 7.12.2 Courier Express Business Overview
  70. 7.12.3 Courier Express Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Courier Express Biomedical Cold Chain Services Product Portfolio
  72. 7.12.5 Courier Express Recent Developments
  73. 7.13 Biocair
  74. 7.13.1 Biocair Company Information
  75. 7.13.2 Biocair Business Overview
  76. 7.13.3 Biocair Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Biocair Biomedical Cold Chain Services Product Portfolio
  78. 7.13.5 Biocair Recent Developments
  79. 7.14 Tower Cold Chain
  80. 7.14.1 Tower Cold Chain Company Information
  81. 7.14.2 Tower Cold Chain Business Overview
  82. 7.14.3 Tower Cold Chain Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Tower Cold Chain Biomedical Cold Chain Services Product Portfolio
  84. 7.14.5 Tower Cold Chain Recent Developments
  85. 7.15 Patheon
  86. 7.15.1 Patheon Company Information
  87. 7.15.2 Patheon Business Overview
  88. 7.15.3 Patheon Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Patheon Biomedical Cold Chain Services Product Portfolio
  90. 7.15.5 Patheon Recent Developments
  91. 7.16 Movianto
  92. 7.16.1 Movianto Company Information
  93. 7.16.2 Movianto Business Overview
  94. 7.16.3 Movianto Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Movianto Biomedical Cold Chain Services Product Portfolio
  96. 7.16.5 Movianto Recent Developments
  97. 7.17 Pharmaceutical Technology
  98. 7.17.1 Pharmaceutical Technology Company Information
  99. 7.17.2 Pharmaceutical Technology Business Overview
  100. 7.17.3 Pharmaceutical Technology Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Pharmaceutical Technology Biomedical Cold Chain Services Product Portfolio
  102. 7.17.5 Pharmaceutical Technology Recent Developments
8 North America
  1. 8.1 North America Biomedical Cold Chain Services Revenue (2021-2032)
  2. 8.2 North America Biomedical Cold Chain Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Biomedical Cold Chain Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Biomedical Cold Chain Services Revenue by Type (2027-2032)
  5. 8.3 North America Biomedical Cold Chain Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Biomedical Cold Chain Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Biomedical Cold Chain Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Biomedical Cold Chain Services Revenue by Application (2027-2032)
  9. 8.5 North America Biomedical Cold Chain Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Biomedical Cold Chain Services Revenue by Country
  11. 8.6.1 North America Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biomedical Cold Chain Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Biomedical Cold Chain Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biomedical Cold Chain Services Revenue (2021-2032)
  2. 9.2 Europe Biomedical Cold Chain Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biomedical Cold Chain Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biomedical Cold Chain Services Revenue by Type (2027-2032)
  5. 9.3 Europe Biomedical Cold Chain Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biomedical Cold Chain Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biomedical Cold Chain Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biomedical Cold Chain Services Revenue by Application (2027-2032)
  9. 9.5 Europe Biomedical Cold Chain Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biomedical Cold Chain Services Revenue by Country
  11. 9.6.1 Europe Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biomedical Cold Chain Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biomedical Cold Chain Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biomedical Cold Chain Services Revenue (2021-2032)
  2. 10.2 China Biomedical Cold Chain Services Revenue by Type (2021-2032)
  3. 10.2.1 China Biomedical Cold Chain Services Revenue by Type (2021-2026)
  4. 10.2.2 China Biomedical Cold Chain Services Revenue by Type (2027-2032)
  5. 10.3 China Biomedical Cold Chain Services Revenue Share by Type (2021-2032)
  6. 10.4 China Biomedical Cold Chain Services Revenue by Application (2021-2032)
  7. 10.4.1 China Biomedical Cold Chain Services Revenue by Application (2021-2026)
  8. 10.4.2 China Biomedical Cold Chain Services Revenue by Application (2027-2032)
  9. 10.5 China Biomedical Cold Chain Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biomedical Cold Chain Services Revenue (2021-2032)
  2. 11.2 Asia Biomedical Cold Chain Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biomedical Cold Chain Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biomedical Cold Chain Services Revenue by Type (2027-2032)
  5. 11.3 Asia Biomedical Cold Chain Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biomedical Cold Chain Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biomedical Cold Chain Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biomedical Cold Chain Services Revenue by Application (2027-2032)
  9. 11.5 Asia Biomedical Cold Chain Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biomedical Cold Chain Services Revenue by Country
  11. 11.6.1 Asia Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biomedical Cold Chain Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biomedical Cold Chain Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biomedical Cold Chain Services Revenue (2021-2032)
  2. 12.2 SAMEA Biomedical Cold Chain Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biomedical Cold Chain Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biomedical Cold Chain Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biomedical Cold Chain Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biomedical Cold Chain Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biomedical Cold Chain Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biomedical Cold Chain Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biomedical Cold Chain Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biomedical Cold Chain Services Revenue by Country
  11. 12.6.1 SAMEA Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biomedical Cold Chain Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biomedical Cold Chain Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research